Compare PIPR & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | GRFS |
|---|---|---|
| Founded | 1895 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.0B |
| IPO Year | N/A | 2006 |
| Metric | PIPR | GRFS |
|---|---|---|
| Price | $355.03 | $9.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $362.50 | $10.15 |
| AVG Volume (30 Days) | 116.5K | ★ 563.8K |
| Earning Date | 01-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.63% | 1.56% |
| EPS Growth | ★ 42.49 | N/A |
| EPS | ★ 13.30 | 0.64 |
| Revenue | $1,717,433,000.00 | ★ $8,821,017,248.00 |
| Revenue This Year | $17.11 | $5.46 |
| Revenue Next Year | $15.11 | $5.60 |
| P/E Ratio | $26.79 | ★ $17.68 |
| Revenue Growth | ★ 13.46 | 7.31 |
| 52 Week Low | $202.91 | $6.19 |
| 52 Week High | $374.77 | $11.14 |
| Indicator | PIPR | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 57.67 |
| Support Level | $332.48 | $8.81 |
| Resistance Level | $372.75 | $9.22 |
| Average True Range (ATR) | 10.17 | 0.26 |
| MACD | 3.78 | 0.08 |
| Stochastic Oscillator | 66.22 | 95.25 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.